# HERCESSI

NDC: 69448-015
Generic name: Trastuzumab-strf
Labeler / Manufacturer: Accord BioPharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250101

FDA application: BLA761346

## Active ingredients

- TRASTUZUMAB-STRF: 150 mg/7.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69448-015"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69448-015